Therapeutic Delivery · 2019 · 40 citations · 31 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryPharmaceutical FormulationNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsNanoparticle DesignNanoparticle FormulationsNasal Drug DeliveryAntidepressant EfficacyDrug Delivery NanocarriersNanoparticle Nasal FormulationsNanoparticle-based Controlled ReleasePoly(lactic-co-glycolic Acid)Poly(lactic-co-glycolic Acid) NanoparticlesPolymeric Nanoparticle EncapsulationPolymeric Nanoparticle Formulation
Aim: The manuscript describes the performance of nanoparticles loaded with antidepressant drug for nose-to-brain drug delivery. Materials & methods: Poly-lactic-co-glycolic acid-loaded nanoparticles of agomelatine were prepared by nanoprecipitation method using poloxamer 407 as stabilizer. The process parameters were optimized using factorial design. Results: The drug-loaded nanoparticles having low particle size (<200 nm) with narrow size distribution and required zeta potential (-22.7 mV) to avoid aggregation showed sustained release profile and were found to have higher permeability as observed from ex vivo studies when compared with plain drug suspension. Histopathology test showed that the optimized formulation was free from nasal toxicity on the goat nasal mucosa. Pharmacodynamic study showed significant reduction in immobility time in rats treated with the formulation which indicated antidepressant activity of the formulation. Conclusion: The prepared agomelatin-loaded poly-lactic-co-glycolic acid nanoparticles showed prominent antidepressant activity by nose-to-brain delivery as observed from various studies.
31
Jeffrey D. Clogston, Anil K. Patri · Methods in molecular biology · 2010 · 1.3K citations
Gaurav Mittal, D.K. Sahana, V. Bhardwaj et al. · Journal of Controlled Release · 2007 · 542 citations